Financial Results - Longevity Health Holdings, Inc. announced preliminary unaudited financial results for Q1 2025, with specific figures to be finalized later[7]. - The company has not yet provided specific revenue figures for the first quarter of 2025, pending finalization of financial statements[7]. Merger Details - The company is in the process of a proposed merger with 20/20 Biolabs, Inc., with expectations regarding the ownership structure and operational synergies post-merger[10]. - The anticipated timing for the closing of the merger is still under discussion, with various conditions that need to be satisfied[10]. - The company is preparing to file relevant materials with the SEC regarding the merger, including a Form S-4 and Proxy Statement[14]. - The merger is expected to result in operational savings and synergies, although specific financial projections are not yet disclosed[10]. - Risks associated with the merger include potential delays in obtaining necessary approvals and maintaining Nasdaq listing[10]. - Management is aware of the significant uncertainties surrounding the merger and its potential impact on future operations[12]. - Investors are encouraged to review all relevant documents filed with the SEC for detailed information regarding the merger[15]. Future Focus - The company is focused on launching and commercializing new products, which is expected to enhance future revenue streams[10].
ALPHA HEALTHCARE(ALPA) - 2025 Q1 - Quarterly Results